Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CEA-based vaccines.

Emina H Huang1, Howard L Kaufman

  • 1Department of Surgery, College of Physicians & Surgeons, Columbia University, New York, NY, USA.

Expert Review of Vaccines
|August 12, 2003
PubMed
Summary

Carcinoembryonic antigen (CEA) vaccines target tumors expressing this antigen. Early trials show these CEA-based vaccines can stimulate immune responses and are being explored for cancer treatment and prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory Stromal Aging in Ulcerative Colitis and Colitis-Associated Cancer.

bioRxiv : the preprint server for biology·2026
Same author

Local immunotherapy for the treatment of cancer: scientific advances and clinical potential.

Journal for immunotherapy of cancer·2026
Same author

Temporal molecular remodeling of T cells informs their possible adaptation in 4T1 tumors.

Computational and structural biotechnology journal·2026
Same author

Targeting Tumor-Draining Lymph Nodes to Improve the Therapeutic Potential of Oncolytic Viruses.

Cancer immunology research·2026
Same author

Locally Advanced Conjunctival Squamous Cell Carcinoma not Responsive to Immune Checkpoint Inhibitor Therapy: 3 Cases and a Literature Review.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Disparities in Colorectal Cancer Presentation at a National Cancer Institute-Designated Cancer Center and a Safety-Net Hospital during the COVID-19 Pandemic.

Medical research archives·2025

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Carcinoembryonic antigen (CEA) is a tumor-associated antigen found in nearly 50% of human tumors.
  • CEA was first cloned in 1987, establishing its significance in cancer research.

Purpose of the Study:

  • To review the development and evaluation of vaccine strategies targeting CEA and CEA-expressing tumors.
  • To discuss the role of CEA-specific immune responses and their monitoring in clinical trials.

Main Methods:

  • Identification of T-cell specific epitopes within the CEA protein.
  • Development and preclinical testing of CEA-based vaccines.
  • Evaluation of vaccine-induced immune responses in early-phase clinical trials using in vitro assays.

Main Results:

  • CEA-based vaccines have demonstrated therapeutic effectiveness in animal models.
  • Early clinical trials are assessing the safety and immunogenicity of these vaccines.
  • In vitro assays provide insights into the induction of CEA-specific immune responses.

Conclusions:

  • CEA-based vaccines show promise for cancer treatment and prevention.
  • Further clinical testing in less advanced disease and combination therapies are needed.
  • Defining the role of CEA vaccines requires continued investigation in human cancer treatment.

Related Experiment Videos